Answers are grounded in this paper and cite their sources.
The second-generation antipsychotic drug quetiapine (Seroquel) is increasingly being used off-label for treating insomnia in the general population, possibly to avoid standard medications with known addictive qualities and adverse side effects. However, evidence to support using it in this way is scant, and quetiapine is associated with weight gain and other metabolic effects. It must be used cautiously and with appropriate monitoring for adverse effects and abuse.
No takes yet. Share an insight, caveat, or question.
Modesto‐Lowe et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: